Profil
Sandeep C.
Kulkarni was the Chief Operating Officer at Immunovant, Inc. in 2018 and 2019.
Anciens postes connus de Sandeep C. Kulkarni
Sociétés | Poste | Fin |
---|---|---|
IMMUNOVANT, INC. | Chief Operating Officer | 01/12/2019 |
Immunovant, Inc. /Old/
Immunovant, Inc. /Old/ BiotechnologyHealth Technology Immunovant, Inc. is a biopharmaceutical company, which engages in the development of therapies for autoimmune diseases. It focuses on its product pipeline, IMVT-1401, which is a human recombinant anti-neonatal Fc receptor monoclonal antibody for the treatment of IgG mediated diseases. The company is headquartered in New York, NY. | Chief Operating Officer | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
IMMUNOVANT, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Immunovant, Inc. /Old/
Immunovant, Inc. /Old/ BiotechnologyHealth Technology Immunovant, Inc. is a biopharmaceutical company, which engages in the development of therapies for autoimmune diseases. It focuses on its product pipeline, IMVT-1401, which is a human recombinant anti-neonatal Fc receptor monoclonal antibody for the treatment of IgG mediated diseases. The company is headquartered in New York, NY. | Health Technology |